Findings may be due to faster atrophy progression in primary progressive MS
Data points from Cleveland Clinic’s 5,646 visits over four years
Disappointing performance for the dual serotonin receptor antagonist
Pairing of novel imaging technique with post-processing analyses could ultimately reshape care
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Insights from 240 cases over 8 years at Cleveland Clinic
Cleveland Clinic study assesses effects of state-level reforms
Dr. Andrew Russman shares priorities, new developments to watch for
Retrospective analysis finds no evidence of benefit, but more study needed
Pilot study supports routine neuropsychological testing before and after the surgery
Advertisement
Advertisement